Daily Stock List
HyperSolar, Inc. (HYSR)
MicroStockProfit, Penny Stocks Finder, Stock Preacher, Beacon Equity Research, Stock Roach, InvestorSoup, PennyStockRumors.net, and TheLightningPicks reported earlier on HyperSolar, Inc. (HYSR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, HyperSolar, Inc. is the developer of a pioneering technology to produce renewable hydrogen using sunlight and any source of water. This includes seawater and wastewater. Hydrogen fuel usage produces pure water as the only byproduct. Through optimizing the science of water electrolysis at the nano-level, the Company's low cost nanoparticles mimic photosynthesis to use sunlight efficiently to separate hydrogen from water, to create environmentally friendly renewable hydrogen. HyperSolar has their headquarters in Santa Barbara, California.
The Company's objective is to facilitate a world of distributed hydrogen production for renewable electricity and hydrogen fuel cell vehicles. This is through using their low cost method to produce renewable hydrogen.
Recently, the Company announced their plan to build renewable hydrogen generators for commercial use. Called the H2Generator, the expectation is that their first commercial product will sell at a considerably lower price than other renewable hydrogen systems that rely on expensive and energy intensive electrolyzers to split water. The design of the HyperSolar H2Generator will be as a linearly scalable and self-contained renewable hydrogen production system. Therefore, the intention for it is to be installed practically anywhere to generate hydrogen fuel for local use. The H2Generator eliminates the need for an electrolyzer.
Concerning the H2Generator Panel, H2Generator Cells will be arranged as a matrix in a flat panel reactor filled with an electrolytic solution. Concerning the H2Generator System, H2Generator Panels can be connected together to scale to any size system to meet application specific hydrogen requirements.
Today, HyperSolar announced that an overview of their patent pending technology using solar powered nanoparticles to produce hydrogen from water has been published in "Nano Letters." This is the monthly peer-reviewed scientific journal published by the American Chemical Society. The article reports the successful demonstration of photoelectrochemically active heterostructures fabricated with inexpensive materials and a protective coating for the semiconductor absorber producing photoelectrochemical activity over many hours in a strongly acidic electrolyte, producing chemical products with light as the only energy input.
HyperSolar, Inc. (HYSR), closed Tuesday's trading session at $0.0085, up 6.25%, on 2,371,800 volume with 52 trades. The average volume for the last 60 days is 529,450 and the stock's 52-week low/high is $0.006/$0.085.
Alternative Energy Partners, Inc. (AEGY)
Stock Analyzer reported today on Alternative Energy Partners, Inc. (AEGY), OTCPicks did earlier, and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Founded in 2008, Alternative Energy Partners, Inc. is a holding company engaged through their subsidiary, Clarrix Energy, LLC, in the business of energy production and management. The Company's largest target market will be the commercial energy market. Alternative Energy Partners will market to industries with an interest in lowering their energy costs or increasing energy efficiency. The Company lists on the OTC Markets' OTCQB.
Alternative Energy Partners acquired Clarrix Energy for 40,000,000 common shares and 5,000,000 Series A Convertible Preferred Shares of the Company. This acquisition closed on May 30, 2012.
Founded in 2011, Clarrix Energy's initial source of revenue is from commissions generated by saving businesses from 1 to 25 percent on their utility bills. The Company indicates that their Management will be searching for products and services for clients, including solar, surge protection, lighting and more. Clarrix Energy provides consultative and brokerage services to business of all sizes. The goal of these services is to decrease utility costs in as many ways as possible for every client. Currently, Clarrix Energy has agreements with energy suppliers in 10 states. The Company is seeking additional supply partners.
Alternative Energy Partners has also entered into an agreement to acquire a deposit of already mined black sand located in New Mexico. This has been independently valued at an estimated $540 million on site, based on an existing geological survey report. The deposit is in excess of 55,000 tons of materials that undergo crushing and milling washed and ready for refining. The Company's objective is to transport the deposit for refining and sale.
In addition, Alternative Energy Partners has entered into an agreement to acquire ownership of the assets of StarPoint USA, Inc. StarPoint is a U.S. based vehicle distribution company. They distribute several different brands/models in the U.S. market. StarPoint has been the exclusive distributor of Daewoo vehicles and Genuine Daewoo Parts to the U.S. market since 1998.
In June 2012, StarPoint secured an exclusive vehicle distribution agreement with a U.S. based alternative fuel vehicle manufacturer for the entire U.S. market. This will involve the distribution of CNG Bi-Fuel and all electric vehicles.
Alternative Energy Partners, Inc. (AEGY), closed Tuesday's trading session at $0.005, up 66.67%, on 95,229,853 volume with 840 trades. The average volume for the last 60 days is 2,441,962 and the stock's 52-week low/high is $0.0001/$0.0033.
American Vanadium Corp. (AVCVF)
Today we are reporting on American Vanadium Corp. (AVCVF), here at the QualityStocks Daily Newsletter.
Listed on the OTC Markets, American Vanadium Corp. is developing the only vanadium mine in the U.S (Nevada). This strategic asset gives them the opportunity to integrate the Company vertically and their vanadium production into the highest value market, grid energy storage. American Vanadium will be seeking major joint venture partners in the solar, wind and grid-scale battery manufacturing industries. The Company has their corporate headquarters in Vancouver, British Columbia.
American Vanadium's Gibellini Project in Nevada is undergoing design to produce vanadium electrolyte economically for the energy storage industry, and vanadium products for the steel and alloying industries. AMEC E&C Services completed a positive Feasibility Study and updated National Instrument 43-101 on the Gibellini Project in 2011.
Vanadium is produced as a by-product of steel smelter slag. In addition, it is mined in two different types of mineral deposits: disseminated in carbon rich deposits and shales (as with the Company's Gibellini Project), and in magnetite (iron oxide) deposits alongside titanium. In its different market applications, vanadium represents a billion dollar industry.
The Gibellini Project represents the opportunity to become North America's first and only primary producer of vanadium. This is while meeting approximately 5 percent of current worldwide vanadium demand. The Gibellini Project is an open pit, heap leach project. It represents one of the lowest cost and most simple vanadium operations to undergo development globally.
The project's NI 43-101 compliant resource represents 131.369 million pounds of measured and indicated vanadium (vanadium pentoxide or V205) grading at 0.285 percent, and an additional 48.96 million pounds of inferred vanadium grading at 0.172 percent. The Gibellini Project consists of 232 unpatented lode claims and 7 placer claims totaling approximately 4,254 acres in Nevada. Opportunities also exist to expand the project further beyond its current definition.
In April, American Vanadium reported that they completed their previously announced non-brokered private placement and issued 1,607,698 units at the price of CDN$0.70 per unit for total gross proceeds to the Company of approximately CDN$1,125,388. The Company will use the net proceeds of the Private Placement for mine design, environmental permitting, as well as general working capital.
American Vanadium Corp. (AVCVF), closed today at $0.816, up 2.77%, on 310,355 volume with 144 trades. The average volume for the last 60 days is 26,107 and the stock's 52-week low/high is $0.331/$1.195.
Coventry Resources, Inc. (CYY.V)
We are highlighting Coventry Resources, Inc. (CYY.V), here at the QualityStocks Daily Newsletter.
Listed on the TSX Venture Exchange, Coventry Resources, Inc. is an enterprise focusing on gold exploration and development in northwestern Ontario, Canada. The Company is advancing the Cameron Gold Camp Project towards production, based on a positive Preliminary Economic Assessment (PEA) Study completed in early 2013 that confirmed favorable economics. Additionally, Coventry holds the second largest land position in the Rainy River District, located next to the Rainy River Gold Deposit.
The Company has started a 5,000-meter, overburden reverse circulation (RC) drill program on their Rainy River District Properties in the southern part of western Ontario. Coventry has also identified several exploration targets along the Cameron Lake Shear Zone and at their highly prospective Rainy River District properties where the Company believes they can continue to expand Coventry's resource base.
In late April, Coventry Resources announced positive results from their recently completed 46 hole, 1,058 meter, overburden RC drill program at their Rainy River District Properties. The Project consists of Coventry's mineral rights covering an area of 132.7 km² adjacent to the Rainy River Gold Deposit owned by Rainy River Resources Ltd.
Highlights include two significant, discrete, high-priority gold anomalies defined; high proportions of "modified" and "pristine" gold grains within these anomalies suggest distance to the primary source of the mineralization to be between 500-1,000 meters, and an additional 15 precious and base metal anomalies were identified.
Yesterday, the Company announced the initial NI 43-101 and JORC-Code (2012 Edition) compliant mineral resource estimate for the Dogpaw Gold Deposit. The Dogpaw Gold Deposit is located 10 km west of the Company's flagship Cameron Gold Deposit. Dogpaw is one of numerous deposits within Coventry's Cameron Gold Camp Project in northwestern Ontario.
Coventry Resources' strategy is to advance satellite deposits that are proximal to the Cameron Gold Deposit, with a goal of providing additional feed to their proposed mining operation at the Cameron Deposit. The Company's plan is to conduct further exploration drilling during the second quarter of this year to evaluate other highly prospective gold zones within the West Cedartree Gold Project, which Coventry recently acquired from Houston Lake Mining, Inc., particularly the Robertson and McLennan Prospects.
Coventry Resources, Inc. (CYY.V), closed Tuesday's trading session at $0.12, down 14.29%, on 5,000 volume. The stock's 52-week low/high is $0.11/$0.42.
Santa Fe Gold Corp. (SFEG)
SmarTrend Newsletters reported this month on Santa Fe Gold Corp. (SFEG), BabyBulls did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Santa Fe Gold Corp. is a mining and exploration enterprise whose shares trade on the OTC Markets' OTCQB. The Company focuses on acquiring and developing gold, silver, copper and industrial mineral properties. Their objective is to build a portfolio of high-quality, diversified mineral assets with an emphasis on precious metals. Santa Fe Gold has their headquarters in Albuquerque, New Mexico.
The Company controls the Summit mine and Lordsburg mill in southwestern New Mexico, which began commercial production in 2012. They also control a major land position near the Lordsburg mill, consisting of the core of the Lordsburg Mining District.
Furthermore, Santa Fe Gold controls the Mogollon gold-silver project, within trucking distance of the Lordsburg mill. They also control the Ortiz gold property in north-central New Mexico; the Black Canyon mica deposit near Phoenix, Arizona; and a deposit of micaceous iron oxide (MIO) in western Arizona.
Yesterday, Santa Fe Gold announced their financial results for the three and nine months ended March 31, 2013. The Company reported record revenues of $13.3 million for the nine months ended March 31, representing a 94 percent increase over the same period of the prior fiscal year. Their earnings from mining operations increased over the period to $3.6 million. This represents a 23 percent increase over the comparable nine-month period in 2012. Revenues for the three months ended March 31, 2013 were $3.3 million. This represents a small increase over the 2012 comparable period.
In January 2013, Santa Fe started a drilling program to test a number of gold-copper targets near the Lordsburg Mill in the Lordsburg Mining District. The goal of the drilling program is the discovery of additional ore for processing through the Lordsburg Mill. During the quarter, 10 diamond core holes totaling 7,288 feet of drilling were completed, aimed at initial testing of 9 targets. Reporting of assay results from the drilling is pending.
The Company continues to sell high-value gold-silver concentrates to two overseas smelters under 2013 sales contracts. The concentrate is produced at their Lordsburg flotation mill. During 2013, Santa Fe Gold is continuing to sell a significant portion of Summit output in the form of silica flux material to two smelters in Arizona.
Santa Fe Gold Corp. (SFEG), closed Tuesday's trading at $0.17, up 22.30%, on 330,769 volume with 64 trades. The average volume for the last 60 days is 61,945 and the stock's 52-week low/high is $0.121/$0.80.
Be Active Holdings, Inc. (JALA)
PennyStocks24, Stock Stars, and MonsterStocksPick reported recently on Be Active Holdings, Inc. (JALA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Great Neck, New York, Be Active Holdings, Inc. manufactures frozen yogurt and fudge bars. The Company provides their products via retail stores in the northeast regions of New York, New Jersey, Connecticut, Massachusetts, Rhode Island, Maine, Pennsylvania, and Ohio. Be Active Holdings offers their Jala Bars. All Natural Jala Frozen Yogurt Bars are the latest product from Marc Wexler and Sam Pugliese. They are the creators of Skinny Cow Ice Cream Bars.
Be Active Holdings makes the bars with naturally fermented yogurt using Streptococcus thermophilus and Lactobacillus bulgaricus yogurt cultures. In addition, they add Lactobacillus acidophilus and Lactobacillus delbrueckii bulgaricus bacteria. Each Jala bar is 110 calories. All three yogurt bars are rich in antioxidants and probiotics. They are also a good source of calcium. Jala Chocolate Fudge Bars are one of the first ice cream products worldwide to feature the potential health benefits of probiotics.
Jala Bars contain antioxidants and bacteria flora. Each bar contains approximately 10 percent of the Recommended Daily Allowance for calcium. They also contain approximately one third of the Recommended Daily Allowances of Vitamins A, C and E.
The Company's products include Low Fat Greek Frozen Yogurt Bars (Chocolate Fudge, Vanilla Blueberry Swirl, and Vanilla Pomegranate Swirl). The Jala Bars have no artificial sweeteners or flavors and the bars are now available in more than 2,500 stores. Their products additionally include Low Fat Greek Frozen Yogurt Pints. Jala pints contain vitamins, antioxidants, as well as active probiotics.
Additionally, Be Active Holdings offers Low Fat Greek Frozen Yogurt Sandwiches. Flavors include Vanilla, Vanilla and Chocolate Combo, and Vanilla and Strawberry Swirl. Each Jala sandwich contains 140 calories.
Earlier this month, Be Active Holdings announced that they completed an $850,000 private placement for their Jala Yogurt expansion. The Company's intention is to use the net proceeds of the Offering for working capital and general corporate purposes. This includes, without limitation, debt reduction purposes.
Be Active Holdings, Inc. (JALA), closed at $0.044, down 4.14%, on 187,253 volume with 14 trades. The average volume for the last 60 days is 881,615 and the stock's 52-week low/high is $1.20/$0.036.
ImmuDyne, Inc. (IMMD)
Today we are reporting on ImmuDyne, Inc. (IMMD), here at the QualityStocks Daily Newsletter.
ImmuDyne, Inc. is a leading research and manufacturing biotechnology firm. The Company focuses on the development of immune system enhancing compounds notably the purest, particulate and reliable Beta Glucan derived from yeast. Their Beta Glucan is patented, GMP compliant, as well as GRAS listed. A health and wellness lifestyle company, Immudyne has a portfolio of unique patent-protected products with applications in the wellness lifestyle, skin care, anti-aging, fitness, and health markets. ImmuDyne has offices in Mount Kisco, New York, Carlsbad, California, and Florence, Kentucky.
ImmuDyne pioneered the research and manufacturing of Beta Glucan. Beta Glucan is a natural extract; Beta Glucans can be found in the cellulose of plants, the bran of cereal grains, the cell wall of baker's yeast, certain fungi, and bacteria. Beta Glucan derived from mushrooms, oats, or barley has not been known to have the same effects on human health as Beta Glucan derived from yeast. Yeast Beta Glucans are notable for their ability to modulate the immune system.
The Company has a staff of employees and advisors with a combined experience of more than 70 years in the applied science of Beta Glucan research and development dedicated to support the innate immune system. They have a 20-year record of accomplishment of producing stable high grade Beta Glucan with a consistent production process. They also use proprietary processes for the production of UltraPure YBG™. The Company's UltraPure Yeast Beta Glucan (YBG™) is a 95 percent pure Beta Glucan, free of yeast by-product and endotoxin.
ImmuDyne's MacroForce Plus C once daily oral capsules contain an exclusive combination of ultra-pure Yeast Beta Glucan and Vitamin C designed to support a normal, healthy immune system. Their Skin Care Essentials Rejuvenating Serum contains patented yeast-derived Beta Glucan and other natural ingredients.
Last month, Immudyne announced that they plan to implement a 15-Month Sales and Marketing Plan to accomplish increased revenue growth. Highlights of the plan include rebranding ImmuDyne with a new strategic focus, introducing new product lines, and expanding into new multi-billion dollar U.S. markets.
ImmuDyne, Inc. (IMMD), closed Tuesday's trading session at $0.3225, up 14.36%, on 218,051 volume with 66 trades. The average volume for the last 60 days is 41,240 and the stock's 52-week low/high is $0.08/$0.32.
ImageWare Systems, Inc. (IWSY)
We are reporting on ImageWare Systems, Inc. (IWSY) today, here at the QualityStocks Daily Newsletter.
ImageWare Systems, Inc. operates in the growing market for software-based identity management solutions. They provide biometric, secure credential, law enforcement and enterprise authorization. Their flagship product is the patented IWS Biometric Engine®. ImageWare Systems has their corporate headquarters in San Diego, California. They also have offices in Portland, Oregon, Washington, D.C., and Ottawa, Ontario. The Company's shares trade on the OTCQB.
ImageWare Systems is also using their proven multi-modal biometric advances to deliver unique mobile capabilities to the wireless, financial services and healthcare sectors. ImageWare Systems' identity management products are used by hundreds of police departments in the U.S. and by dozens of government and private sector clients in the U.S., Canada, Mexico, Australia and Japan.
The IWS Biometric Engine® is scalable for small business or worldwide deployment. It is a multi-biometric platform. The IWS Biometric Engine® is hardware, software and algorithm independent; this allows for the enrollment and management of unlimited population sizes. The identification products are used to issue and manage secure credentials. These include national IDs, passports, driver licenses, smart cards and access control credentials.
The law enforcement products provide public safety with integrated mug shot, fingerprint LiveScan and investigative capabilities. The Company also provides all-inclusive authentication security software. Elements of the IWS Biometric Engine can be used as investigative tools for law enforcement using multiple biometrics and forensic data elements, and to enhance security and authenticity of public and private sector credentials.
Three foundational technologies form the basis of the Company's multi-modal biometric and credentialing offerings. These are Multi-Modal Biometric Matching, Multi-Modal Biometric Capture, and Credential Issuance. ImageWare's products include the IWS CloudID™ Product Suite, the IWS Interactive Messaging System, the PillPhone®, as well as Foundational Products (IWS Biometric Engine®, IWS Desktop Security, IWS EPI Builder, IWS EPI® Suite, and IWS Law Enforcement.
During the first quarter of 2013, ImageWare Systems entered into a contract with Fujitsu to market a cloud-based, multi-modal biometric identity management offering delivered on the Fujitsu Global Cloud Platform (FGCP). The FGCP features ImageWare's CloudID™ product suite that is anchored by their patented, multi-modal Biometric Engine® 2.0.
Subsequent to the first quarter, the FGCP was marketed in North America. Consequently, ImageWare Systems secured their first agreement in connection with this contract. Last Friday, they announced an agreement with Emida to provide cloud identity management services for mobile wallet subscribers and partners using their patented CloudID software-as-a-service. The solution will run on top of the FGCP. Emida is a leader in the global prepayment and value transfer market.
ImageWare Systems, Inc. (IWSY), closed today at $1.24, up 9.73%, on 161,749 volume with 89 trades. The average volume for the last 60 days is 159,120 and the stock's 52-week low/high is $0.41/$1.33.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.278, up 6.92%, on 193,880,308,715 volume with 62 trades. The stock’s average daily volume over the past 60 days is 112,675, and its 52-week low/high is $0.161/$0.45.
International Stem Cell Corp. showed some nice results today as Q1 results hit the wires, offering such highlights as a 19% jump in revenues over the prior year's Q1 to $1.29M, on double-digit sales increases from both the Lifeline Cell Technologies and Lifeline Skin Care units. A 4% reduction in cost of sales, combined with a 30% claw-back of general and administrative expenses, roundly improved gross margins, and solid safety/efficacy pre-clinical results in congenital liver disorder and Parkinson's disease, comprised the excellent quarter.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
ISCO Announces First Quarter 2013 Financial Results and Provides Business Update
International Stem Cell Corporation to Host Q1 2013 Financial Results Conference Call at 11:00 a.m. ET on Tuesday, May 14, 2013
International Stem Cell Corporation to Present at American Society of Gene and Cell Therapy 16th Annual Meeting
GNCC Capital, Inc. (GNCP)
The QualityStocks Daily Newsletter would like to spotlight GNCC Capital, Inc. (GNCP). Today, GNCC Capital, Inc. closed trading at $0.0097, up 21.25%, on 179,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 375,507, and its 52-week low/high is $0.0055/$0.09.
GNCC Capital, Inc. (GNCP) is a gold and silver exploration company with six different projects, all of which were carefully selected due to their outstanding characteristics. The company’s geologists will supervise an extensive exploration program for these projects to prove up reserves through geological surveys and a substantial number of carefully planned drilling programs.
The company’s initial exploration properties, located in Arizona, consist of Esther Basin, Burnt Well, Clara Gold, Kit Carson, Silverfields, and Potts Mountain. GNCC Capital plans to create significant value for its initial properties portfolio through continued exploration and joint ventures, as well as through acquiring additional gold and silver exploration assets.
GNCC Capital currently holds circa 80% of its assets in gold exploration properties. The strong rise in gold prices over recent years make this company attractive to investors seeking to benefit from the increasing value of precious metals. Backed by a world-class management team with decades of experience in the financial and mining sectors, GNCC Capital is well positioned to capitalize on the upward trend.
The company’s focus is creating value for its shareholders, employees, and business and social partners through responsible and safe exploration, mining, and marketing. While gold exploration is the company’s main focus, GNCC Capital will take advantage of value-creating opportunities in other minerals where it can leverage existing assets, skills, and experience. Disclaimer
GNCC Capital, Inc. Company Blog
GNCC Capital, Inc. News:
GNCC Capital, Inc. to Complete Acquisition
GNCC Capital, Inc. Update on Potential Acquisition
GNCC Capital, Inc. Evaluates Acquisition
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.051, up 8.51%, on 2,744,039 volume with 78 trades. The stock’s average daily volume over the past 60 days is 2,292,014, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Announces 2013 Annual Meeting of Stockholders
Advaxis Announces Promotion of Dr. Robert Petit and Daniel J. O’Connor
Advaxis Reports Encouraging Preliminary Data from Penn Phase 1 ADXS-cHER2 Canine Osteosarcoma Study
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0156, up 6.12%, on 597,933 volume with 20 trades. The stock’s average daily volume over the past 60 days is 678,571, and its 52-week low/high is $0.0013/$0.0158.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE's Giant King Grass to Biogas for Electricity Paper Presented at International Biomass Conference
VIASPACE 7 MW Power Purchase Agreement Nearly Finalized in St. Croix, Giant King Grass Growing Well
VIASPACE and AGRICORP Partnership on Giant King Grass in Nicaragua: 12 MW Biomass Power Plant Targeted
International Stem Cell, a biotech company developing novel stem cell-based therapies, today reported its financial results for the first quarter ended March 31, 2013.
Quarterly revenues increased 19 percent to $1.29 million from $1.08 million reported in the first quarter of the year prior. Revenues for Lifeline Skin Care (LSC) increased by 19 percent while revenue for Lifeline Cell Technology (LCT) increased by 20 percent, accounting for 51 percent and 49 percent of total quarterly revenue, respectively.
ISCO posted a first-quarter loss of $0.02 per share, narrowed compared to a loss of $0.05 per share for the comparable quarter a year ago.
Gross margin improved by 410 basis points to 74.0 percent while general and administrative expenses reduced by 30 percent to $1.42 million.
Marketing expenses increased 3 percent to $0.51 million, primarily reflecting higher spending on advertising and promotions for the company’s skin care business.
Cash and cash equivalents totaled $1.91 million at March 31, 2013, compared to $0.65 million as of December 31, 2012.
” … the strong sales growth achieved by our subsidiaries confirms that the sales and marketing tactics we have been implementing are starting to deliver the results we anticipated and begin to partially offset our core Research and Development expenses,” Dr. Andrey Semechkin, ISCO CEO and co-chairman stated in the press release. “At the same time we continue to challenge ourselves to become ever more efficient and this continued vigilance is reflected in both the reduced general and administrative expenses and increased gross margin.”
For more information, visit www.internationalstemcell.com
VentriPoint Diagnostics, a Seattle based imaging technology company, has developed an important proprietary system that provides a uniquely simple and cost effective way of imaging various heart functions, offering the promise of significantly lower diagnostic and support costs for hospitals and patients. Its current focus is on the diagnosis of congenital heart disease in adults and children, due largely to its remarkable ability for imaging of the right ventricle, but other applications are already being developed.
The VentriPont Angelo (VMS™) imaging system is based upon what is called Knowledge Based Reconstruction (KBR), a way of generating an accurate 3-dimensional surface from basic ultrasound 2-dimensional data, by fitting points which the user enters at anatomic landmarks, avoiding all of the operational and economic disadvantages of complex MRI scanning.
KBR is based on the piecewise smooth subdivision surface reconstruction method, the most anatomically accurate 3D surface reconstruction method reported to date and the only reconstruction method proven to provide faithful representation of 3D shape and volume. It’s fast, taking just a few minutes per volume measurement, and requiring the user to provide a very sparse input of points as opposed to whole borders. The user can choose the highest quality images to trace those points, meaning that the user is free to work just on the images where each part of the ventricle is best seen. Tests have shown KBR to have excellent accuracy in the measurement of right ventricular volume at both end diastole (EDV) and end systole (ESV).
The VentriPont system is currently installed in hospitals throughout the U.S., Canada, and Europe, and is now in the process of enabling dozens of additional centers, expanding the applications beyond congenital heart disease in adults and children.
For additional information, visit www.VentriPoint.com
GlobalWise, through its Intellinetics subsidiary, provides a uniquely user and system friendly ECM (Enterprise Content Management) solution that allows all types of commercial and public organizations to get a handle on what can seem to be an endlessly increasing volume of documents, important items that can be buried and lost without proper management. The company’s primary ECM product, called Intellivue, is similar to the traditional pay-per-click approach, but with a fixed-cost model that appeals to a wider customer base, relieving the user of concerns about excessive unforeseen charges. The company’s monthly fee approach, involving no up-front costs, can be especially attractive to the small and medium business clients targeted by GlobalWise, a business stratum not focused on by similar services.
According to Gartner, Inc., the ECM industry should exceed $5.7 billion by 2014, with a compounded annual growth rate of over 10%. Major ECM players target only large Tier 1 and Tier 2 businesses, leaving thousands of smaller businesses with virtually no ECM providers, representing a major opportunity which GlobalWise is actively pursuing. A convergence of advanced ECM software capabilities plus developing mobile platform technologies now makes the company’s sophisticated cloud based processing and communication capabilities available to even small companies, allowing secured access to vital information available 24/7 on a worldwide basis. Today, leading hardware vendors, including Lexmark, Samsung, and DELL, directly integrate their hardware with the Intellivue cloud platform.
GlobalWise represents a significantly lower cost delivery model, while still offering comprehensive ECM functionality, such as Transaction Content Management, Social Content Management, On-line Channel Optimization, and Content Management as Infrastructure. In addition, it offers customized solutions for all types of organizational requirements and industries, and supports both iPhone and Android OS mobile platforms.
For information on GlobalWise and its subsidiary visit www.GlobalWiseInvestments.com andwww.Intellinetics.com
Great Panther has assembled an enviable position in the rich mineral wealth of Mexico, with some 22.5k acres of 100%-owned claims/concessions between just the flagship Guanajuato silver-gold mine complex and their Topia high-grade silver-lead-zinc mine, making it little surprise today that GPL announced they have tapped 24-year industry veteran geologist, Geoff Chater, for the company’s Board, along with two other key appointments to the Mexico management team’s senior personnel.
You can have a superb footprint of producing mineral assets like GPL, who is on track to churn out some 2.5M silver-equivalent ounces in fiscal 2013, but you still need the right personnel to make it all happen. Hence the significance of Chater joining the operation, as this B.Sc. Geology veteran has spent more than his fair share of time across North and South America, as well as Africa, gaining the kind of mining industry depth that will really help the GPL Board move the ball down the field operationally, especially considering his emphasis on the capital markets sector.
Chater is the principal over at esteemed capital markets relationship development, communications advice, corporate strategy, financing, and transaction related business development consultancy, Namron Advisors, and is also currently a Director at Bearing Resources, Kiska Metals, Lara Exploration, Luna Gold, and Reservoir Minerals. He comes to the Director role at GPL hot off a recent stint as President of Valley High Ventures Ltd., prior to which he headed up Corporate Relations for First Quantum Minerals Ltd. (1999-2008), serving with distinction in even earlier work at top industry names like Eldorado Gold Corp., Ivanhoe Capital Corp., and Nevada Pacific Gold Ltd.
In addition to this important Board expansion, GPL specifically beefed up the Senior Management Team for Mexico operations as well, tagging Guanajuato-based industry veterans Juan Manuel Flores (who alone has over 35 years in the game) and Cesar Epifanio, for the roles of VP Operations and VP SH&E (safety, health and environment) respectively. Flores brings another B.Sc. in Mining to the table and also holds a B.Sc. in Metallurgical Engineering, with a Master of Science in Mineral Economics. Epifanio brings an exceptional SH&E track record across many other companies to the table, along with a degree in Industrial Engineering, as well as one in Health and Safety.
This news comes fast on the heels of GPL’s Mexican subsidiary winning the “Socially Responsible Company” designation by leading Mexican authority CEMEFI (Centro Mexicano para la Filantropia) for the third straight year in a row, a status that the company is laser-focused on maintaining. Hard to imagine this up-and-comer failing to hold onto that distinction with such visionary appointment work to the company’s team going on.
For more info check out the Great Panther Silver Ltd. Site at www.GreatPanther.com
Today's Top 3
Information Solutions Group
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Announces 2013 Annual Meeting of Stockholders
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Announces Move to Protect Shareholders by Cancelling 50k Preferred Shares, 5.74M Common A Shares
- GNCC Capital, Inc. (GNCP) to Complete Acquisition
- GlobalWise Investments, Inc. (GWIV) Reports Financial Results for First Quarter 2013
- International Stem Cell Corp. (ISCO) to Host Q1 2013 Financial Results Conference Call at 11:00 a.m. ET on Tuesday, May 14, 2013
- Loans4Less.com, Inc. (LFLS) Announces Financial Results for Q1 2013
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Partner n3D Signs U.S. Distribution Agreement
- The Aristocrat Group Corp. (ASCC) Teams up With Experienced Ad Firm to Drive Sales of Debut Vodka
- The Guitammer Company Inc. (GTMM) and Digiplex Join Forces to Offer "4D Powered by ButtKicker" to Movie Goers
- VentriPoint Diagnostics Ltd. (VPTDF) Announces Private Placements
- Viaspace, Inc. (VSPC) Giant King Grass to Biogas for Electricity Paper Presented at International Biomass Conference
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue